Our results showed that ITGA3 had a negative correlation with B cell markers (CD19 and CD79a), suggesting that the low expression of ITGA3 in BRCA might promote B cell infiltration and lead to immunosuppression. Here, CD19 is linked to invasive breast carcinoma.